Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2016, Article ID 6028971, 7 pages
http://dx.doi.org/10.1155/2016/6028971
Clinical Study

Heavy Alcohol Drinking Associated Akathisia and Management with Quetiapine XR in Alcohol Dependent Patients

1University of Louisville School of Medicine, University of Louisville, Louisville, KY, USA
2Robley Rex VA Medical Center, Louisville, KY, USA

Received 30 April 2016; Revised 28 August 2016; Accepted 5 October 2016

Academic Editor: Ildiko Racz

Copyright © 2016 Zimple Kurlawala and Vatsalya Vatsalya. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Mukherjee, “Alcoholism and its effects on the central nervous system,” Current Neurovascular Research, vol. 10, no. 3, pp. 256–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Mostile and J. Jankovic, “Alcohol in essential tremor and other movement disorders,” Movement Disorders, vol. 25, no. 14, pp. 2274–2284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Koller, D. Graner, and A. Mlcoch, “Essential voice tremor: treatment with propranolol,” Neurology, vol. 35, no. 1, pp. 106–108, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. A. F. Mubaidin, “Alcohol with xylocaine for treatment of eyelid dystonia,” European Journal of Neurology, vol. 7, no. 2, pp. 213–215, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. K. R. Muller-Vahl, H. Kolbe, and R. Dengler, “Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms,” Nervenarzt, vol. 68, no. 12, pp. 985–989, 1997. View at Publisher · View at Google Scholar
  6. M. Demirkiran and J. Jankovic, “Paroxysmal dyskinesias: clinical features and classification,” Annals of Neurology, vol. 38, no. 4, pp. 571–579, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. M. K. Bruno, H.-Y. Lee, G. W. J. Auburger et al., “Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia,” Neurology, vol. 68, no. 21, pp. 1782–1789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. R. Kosten and P. G. O'Connor, “Management of drug and alcohol withdrawal,” New England Journal of Medicine, vol. 348, no. 18, pp. 1786–1795, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Sattar, S. C. Bhatia, and F. Petty, “Potential benefits of quetiapine in the treatment of substance dependence disorders,” Journal of Psychiatry and Neuroscience, vol. 29, no. 6, pp. 452–457, 2004. View at Google Scholar · View at Scopus
  10. E. P. Monnelly, D. A. Ciraulo, C. Knapp, J. LoCastro, and I. Sepulveda, “Quetiapine for treatment of alcohol dependence,” Journal of Clinical Psychopharmacology, vol. 24, no. 5, pp. 532–535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. W. M. Glazer, “Review of incidence studies of tardive dyskinesia associated with typical antipsychotics,” Journal of Clinical Psychiatry, vol. 61, supplement 4, pp. 15–20, 2000. View at Google Scholar · View at Scopus
  12. P. Shotbolt, M. Samuel, and A. David, “Quetiapine in the treatment of psychosis in Parkinson's disease,” Therapeutic Advances in Neurological Disorders, vol. 3, no. 6, pp. 339–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. G. Potkin, G. M. Gharabawi, A. J. Greenspan et al., “A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization,” Schizophrenia Research, vol. 85, no. 1–3, pp. 254–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Reddy, S. A. Factor, E. S. Molho, and P. J. Feustel, “The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia,” Movement Disorders, vol. 17, no. 4, pp. 676–681, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Peuskens and C. G. G. Link, “A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia,” Acta Psychiatrica Scandinavica, vol. 96, no. 4, pp. 265–273, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Gandal and D. H. Geschwind, “The genetics-driven revival in neuropsychiatric drug development,” Biological Psychiatry, vol. 79, no. 8, pp. 628–630, 2016. View at Publisher · View at Google Scholar
  17. E. G. Lutz, “Neuroleptic induced akathisia and dystonia triggered by alcohol,” Journal of the American Medical Association, vol. 236, no. 21, pp. 2422–2423, 1976. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Neiman, A. E. Lang, L. Fomazzari, and P. L. Carlen, “Movement disorders in alcoholism: a review,” Neurology, vol. 40, no. 5, pp. 741–746, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Fornazzari and P. L. Carlen, “Transient choreiform dyskinesias during alcohol withdrawal,” Canadian Journal of Neurological Sciences, vol. 9, no. 2, pp. 89–90, 1982. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Baynes, C. Mulholland, S. J. Cooper et al., “Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment,” Schizophrenia Research, vol. 45, no. 1-2, pp. 47–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Z. Litten, J. B. Fertig, D. E. Falk et al., “A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate xr in very heavy-drinking alcohol-dependent patients,” Alcoholism: Clinical and Experimental Research, vol. 36, no. 3, pp. 406–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. Pettinati and S. O'Malley, “Predictors of response in treating alcohol dependence,” Alcoholism-Clinical and Experimental Research, vol. 28, no. 5, p. 184a, 2004. View at Google Scholar
  23. L. C. Sobell, S. Agrawal, M. B. Sobell et al., “Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems,” Journal of Studies on Alcohol, vol. 64, no. 6, pp. 858–861, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Montgomery and M. Asberg, “A new depression scale designed to be sensitive to change,” British Journal of Psychiatry, vol. 134, no. 4, pp. 382–389, 1979. View at Publisher · View at Google Scholar · View at Scopus
  25. T. R. E. Barnes, “The barnes akathisia rating scale—revisited,” Journal of Psychopharmacology, vol. 17, no. 4, pp. 365–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Pilowsky and L. T. Wu, “Screening for alcohol and drug use disorders among adults in primary care: a review,” Journal of Substance Abuse and Rehabilitation, vol. 3, no. 1, pp. 25–34, 2012. View at Google Scholar
  27. J. E. Lipmski Jr. and G. S. Zubenko, “Propranolol in the treatment of neuroleptic-induced akathisia,” The American Journal of Psychiatry, vol. 141, no. 3, pp. 412–415, 1984. View at Publisher · View at Google Scholar
  28. M. Bartels, K. Heide, K. Mann, and H. W. Schied, “Treatment of akathisia with lorazepam. An open clinical trial,” Pharmacopsychiatry, vol. 20, no. 2, pp. 51–53, 1987. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. G. Laoutidis and C. Luckhaus, “5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis,” International Journal of Neuropsychopharmacology, vol. 17, no. 5, pp. 823–832, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. E. S. Brown, D. Davila, A. Nakamura et al., “A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence,” Alcoholism: Clinical and Experimental Research, vol. 38, no. 7, pp. 2113–2118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. R. E. Barnes, “A rating scale for drug-induced akathisia,” British Journal of Psychiatry, vol. 154, pp. 672–676, 1989. View at Publisher · View at Google Scholar · View at Scopus
  32. P. L. Carlen, M. A. Lee, M. Jacob, and O. Livshits, “Parkinsonism provoked by alcoholism,” Annals of Neurology, vol. 9, no. 1, pp. 84–86, 1981. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Fu, A. C. Heath, K. K. Bucholz et al., “Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men,” Archives of General Psychiatry, vol. 59, no. 12, pp. 1125–1132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Boden and D. M. Fergusson, “Alcohol and depression,” Addiction, vol. 106, no. 5, pp. 906–914, 2011. View at Publisher · View at Google Scholar · View at Scopus